 <h1>Uptravi Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>selexipag</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about selexipag. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Uptravi.</p><h2>In Summary</h2><p><b>Common side effects of Uptravi include:</b> diarrhea, headache, jaw pain, limb pain, myalgia, nausea, vomiting, and flushing. <b>Other side effects include:</b> anemia, and decreased appetite.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to selexipag: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, selexipag (the active ingredient contained in Uptravi) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking selexipag:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Blue lips and fingernails</li>
<li>chest pain</li>
<li>coughing that sometimes produces a pink frothy sputum</li>
<li>difficult, fast, noisy breathing</li>
<li>increased sweating</li>
<li>pale skin</li>
<li>swelling in the legs and ankles</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of selexipag may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Decreased appetite</li>
<li>diarrhea</li>
<li>feeling of warmth</li>
<li>headache</li>
<li>joint pain</li>
<li>muscle aching or cramping</li>
<li>muscle pains or stiffness</li>
<li>nausea</li>
<li>pain in the jaw, arms, or legs</li>
<li>rash</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>swollen joints</li>
<li>vomiting</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to selexipag: oral tablet</i></p><h3>General</h3><p>The most frequently reported side effects included headache, diarrhea, jaw pain, nausea, myalgia, vomiting, pain in extremity, and flushing.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 65%)</p>
<p><b>Frequency not reported</b>: Burning sensation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 42%), nausea (up to 34%), vomiting (up to 18%)</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, dyspepsia, abdominal discomfort</p>
<p><b>Frequency not reported</b>: Ascites<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Jaw pain (26%), pain in extremity (up to 17%), myalgia (up to 16%), arthralgia (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Musculoskeletal pain, neck pain</p>
<p><b>Frequency not reported</b>: Bone pain<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Flushing (up to 12%), sinus tachycardia (up to 11.3%)</p>
<p><b>Common</b> (1% to 10%): Hypotension</p>
<p><b>Frequency not reported</b>: Hot flush<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (11%)</p>
<p><b>Common</b> (1% to 10%): Urticaria, erythema<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Nasopharyngitis (13%)</p>
<p><b>Common</b> (1% to 10%): Nasal congestion</p>
<p><b>Frequency not reported</b>: Pulmonary veno-occlusive disease<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Hyperthyroidism, thyroid stimulating hormone decreased<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia, hemoglobin decreased<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Appetite decreased<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Eye pain, retinal disorder<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Malignancy<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, pyrexia, pain, influenza, weight decreased<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Acute renal failure</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Uptravi (selexipag)." Actelion Pharmaceuticals US Inc, South San Francisco, CA. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What is the drug Uptravi used for?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Uptravi (selexipag)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>19 Reviews</li>
<li>Drug class: agents for pulmonary hypertension</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Uptravi &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Pulmonary Hypertension</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to selexipag: oral tablet</i></p><h3>General</h3><p>The most frequently reported side effects included headache, diarrhea, jaw pain, nausea, myalgia, vomiting, pain in extremity, and flushing.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 65%)</p><p><b>Frequency not reported</b>: Burning sensation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 42%), nausea (up to 34%), vomiting (up to 18%)</p><p><b>Common</b> (1% to 10%): Abdominal pain, dyspepsia, abdominal discomfort</p><p><b>Frequency not reported</b>: Ascites<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Jaw pain (26%), pain in extremity (up to 17%), myalgia (up to 16%), arthralgia (up to 11%)</p><p><b>Common</b> (1% to 10%): Musculoskeletal pain, neck pain</p><p><b>Frequency not reported</b>: Bone pain<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Flushing (up to 12%), sinus tachycardia (up to 11.3%)</p><p><b>Common</b> (1% to 10%): Hypotension</p><p><b>Frequency not reported</b>: Hot flush<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (11%)</p><p><b>Common</b> (1% to 10%): Urticaria, erythema<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Nasopharyngitis (13%)</p><p><b>Common</b> (1% to 10%): Nasal congestion</p><p><b>Frequency not reported</b>: Pulmonary veno-occlusive disease<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Hyperthyroidism, thyroid stimulating hormone decreased<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia, hemoglobin decreased<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Appetite decreased<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Eye pain, retinal disorder<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Malignancy<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, pyrexia, pain, influenza, weight decreased<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Acute renal failure</p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Uptravi (selexipag)." Actelion Pharmaceuticals US Inc, South San Francisco, CA. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What is the drug Uptravi used for?</li>
</ul><h2>More about Uptravi (selexipag)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>19 Reviews</li>
<li>Drug class: agents for pulmonary hypertension</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Uptravi &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Pulmonary Hypertension</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>